Carasent ASA - Carasent AB (publ) has been approved for listing on Nasdaq Stockholm
Nasdaq Stockholm has today notified Carasent AB (publ) (“Carasent” or the “Company”) of its assessment that the Company fulfills Nasdaq Stockholm’s listing requirements. Nasdaq Stockholm will approve an application for admission to trading of the Company’s shares, subject to the fulfilment of certain customary conditions, including the approval and registration of a prospectus by the Swedish Financial Supervisory Authority.
As announced on 30 August 2024 the Carasent ASA board of directors resolved on a cross-border merger plan to effect the planned relisting of its shares on Nasdaq Stockholm. Carasent ASA’s Extraordinary General Meeting approved the merger plan on 4 October 2024 as previously announced. The cross-border merger is expected to be completed on 4 December 2024, upon which shareholders will have their shares in Carasent ASA one for one exchanged with shares in Carasent.
The last day of trading on Oslo Børs is expected to be 4 December 2024 and the first day of trading on Nasdaq Stockholm is expected to be 9 December 2024. The dates can be changed and if so, this will be announced in a stock exchange announcement.
Shareholders in Carasent ASA are recommended to contact their bank to make sure that their accounts can hold Swedish listed shares ahead of the relisting. For further information please see https://carasent.com/investors and https://www.nordnet.no/no/kampanjer/carasent.
For further information, please contact
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493